🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

5.977.099

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 2 días
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
15/06/2026 0,8200 USD
13/03/2026 0,8200 USD
15/12/2025 0,7900 USD
15/09/2025 0,7900 USD
13/06/2025 0,7900 USD
14/03/2025 0,7900 USD
13/12/2024 0,7700 USD
13/09/2024 0,7700 USD
14/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7500 USD
14/09/2023 0,7500 USD
14/06/2023 0,7500 USD
14/03/2023 0,7500 USD
14/12/2022 0,7300 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/03/2020 73,87 74,49 69,34 69,66 -5,81% 6,97% 24.138.100
24/03/2020 75,13 75,83 72,11 73,96 +1,86% 4,95% 20.608.100
23/03/2020 75,30 75,30 68,86 72,61 -0,89% 8,55% 19.875.200
20/03/2020 79,50 81,60 72,17 73,26 -6,73% 11,86% 35.110.200
19/03/2020 80,98 85,97 78,29 78,55 -1,10% 9,48% 46.268.200
18/03/2020 73,61 80,00 72,97 79,42 +6,58% 9,55% 34.965.900
17/03/2020 70,00 76,08 69,00 74,52 +8,16% 10,11% 28.823.700
16/03/2020 67,24 72,80 64,41 68,90 -2,61% 12,48% 26.764.600
13/03/2020 71,93 72,00 67,50 70,75 +3,16% 6,26% 30.116.100
12/03/2020 70,44 72,86 67,88 68,58 -6,95% 7,07% 26.364.600
11/03/2020 73,90 75,38 72,78 73,70 +1,88% 3,52% 32.018.600
10/03/2020 75,51 75,56 68,78 72,34 -1,61% 8,98% 27.660.000
09/03/2020 77,92 78,19 73,09 73,52 -8,35% 6,55% 32.839.400
06/03/2020 75,32 80,40 75,10 80,22 +5,37% 7,04% 31.704.700
05/03/2020 75,00 77,50 74,53 76,13 +0,16% 3,96% 22.727.600
04/03/2020 74,90 76,01 72,59 76,01 +2,43% 4,57% 23.741.700
03/03/2020 74,27 74,82 71,51 74,21 -1,58% 4,46% 24.482.000
02/03/2020 70,32 75,41 70,08 75,40 +8,71% 7,58% 31.113.000
28/02/2020 70,17 71,08 66,63 69,36 -4,54% 6,34% 33.786.900
27/02/2020 78,31 78,88 72,26 72,66 -2,73% 8,45% 51.482.500
26/02/2020 71,32 75,47 70,72 74,70 +6,56% 6,66% 35.000.500
25/02/2020 73,73 73,85 69,02 70,10 -3,84% 6,55% 39.199.200
24/02/2020 73,89 74,52 71,59 72,90 +4,59% 3,97% 42.905.000
21/02/2020 67,18 69,78 66,81 69,70 +4,03% 4,42% 22.478.200
20/02/2020 67,26 67,36 66,10 67,00 -0,52% 1,87% 8.697.200
19/02/2020 67,20 67,54 66,82 67,35 +0,51% 1,07% 7.754.000
18/02/2020 67,56 67,80 66,71 67,01 -0,81% 1,61% 9.904.700
14/02/2020 67,41 67,66 67,04 67,56 +1,14% 0,92% 9.109.100
13/02/2020 67,13 67,77 66,52 66,80 -0,22% 1,86% 8.031.000
12/02/2020 67,50 67,82 66,32 66,95 -1,20% 2,22% 13.927.100